These miRNAs disrupt the balance between regulatory T cells (Tregs) and T helper 17 (Th17) cells by inhibiting the signal transducer and activator of the transcription 3 (STAT3) pathway, further promoting an immunosuppressive tumor microenvironment [47]. The gene discussed is STAT3; the disease is neoplasm.